The effect of He-Ne laser (632.8 nm) and Solcoseryl™ in vitro

He-Ne laser (632.8 nm) and Solcoseryl (TM) (SS), a non-protein calf haemodialysate, were used in the enhancement of wound healing. Nonetheless, a study on the use of He-Ne laser with SS has not been done. The purpose of this study is to determine the effect of He-Ne laser biostimulation in combination with SS on Chinese hamster ovary (CHO) and human skin fibroblast (HSF). A dose response for the cloning efficiency (CE) of CHO and HSF cells in 5% fetal bovine serum in minimum essential medium (FBS-MEM) with 6-125 mug/ml SS and He-Ne laser using an optimum power density of 1.25 mW/cm(2) and cumulative doses (CD) of 60-600 mJ/cm(2) given for three consecutive days, were done. The combined effects of He-Ne laser 180 mJ/cm(2) with 6 and 12 mug/ml SS were determined. Quadruplicate cultures were done. Student t-test was used to determine differences of treatment groups from controls. CHO and HSF CE were increased using 180 mJ/cm(2) laser by 13.1% +/- 4.5% (p < 0.0025) and 39.1% +/- 7.9% (p < 0.0005); SS mug/ml by 14.4% +/- 8.7% (p = 0.01) and 20.7% +/- 10.9% (p = 0.01); SS 12 mug/ml by 17.7% +/- 6.3% (p = 0.001) and 23.9% +/- 5.6% (p < 0.0025); laser+SS 6 mug/ml by 15.1% +/- 8.8% (p < 0.01) and 60.9% +/- 9.4% (p < 0.0001); laser+SS 12 mug/ml by 23.0% +/- 1.5% (p < 0.0001) and 70.7% +/- 11.4% (p < 0.0001), respectively. Additional significant increases in CE were observed on CHO using laser+SS 12 mug/ml by 8.6% +/- 1.3% (p < 0.025) and on HSF using laser+SS 6 mug/ml and laser+SS 12 mug/ml by 15.6% +/- 6.8% (p < 0.025) and 22.7% +/- 10.6% (p = 0.01), respectively, when compared to the effect of 180 mJ/cm(2) laser. Results suggest that further stimulation can be achieved by using He-Ne laser with SS. This could be exploited as a new treatment modality.